Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Personalized Medicine Market

ID: MRFR/HC/43636-HCR
200 Pages
Satyendra Maurya
Last Updated: April 06, 2026

India Personalized Medicine Market Research Report By Product Outlook (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness), By Application Outlook (Oncology, CNS, Immunology, Respiratory, Others) and By End-User Outlook (Hospitals, Diagnostic Centers, Research Academic Institutes, Others) -Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Personalized Medicine Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Security, Access Control and Robotics, BY Product (USD Billion)
  49.     4.1.1 Personalized Medicine Diagnostics
  50.     4.1.2 Personalized Medicine Therapeutics
  51.     4.1.3 Personalized Medical Care
  52.     4.1.4 Personalized Nutrition and Wellness
  53.   4.2 Security, Access Control and Robotics, BY Application (USD Billion)
  54.     4.2.1 Oncology
  55.     4.2.2 CNS
  56.     4.2.3 Immunology
  57.     4.2.4 Respiratory
  58.     4.2.5 Others
  59.   4.3 Security, Access Control and Robotics, BY End-User (USD Billion)
  60.     4.3.1 Hospitals
  61.     4.3.2 Diagnostic Centers
  62.     4.3.3 Research & Academic Institutes
  63.     4.3.4 Others
  64. 5 SECTION V: COMPETITIVE ANALYSIS
  65.   5.1 Competitive Landscape
  66.     5.1.1 Overview
  67.     5.1.2 Competitive Analysis
  68.     5.1.3 Market share Analysis
  69.     5.1.4 Major Growth Strategy in the Security, Access Control and Robotics
  70.     5.1.5 Competitive Benchmarking
  71.     5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics
  72.     5.1.7 Key developments and growth strategies
  73.       5.1.7.1 New Product Launch/Service Deployment
  74.       5.1.7.2 Merger & Acquisitions
  75.       5.1.7.3 Joint Ventures
  76.     5.1.8 Major Players Financial Matrix
  77.       5.1.8.1 Sales and Operating Income
  78.       5.1.8.2 Major Players R&D Expenditure. 2023
  79.   5.2 Company Profiles
  80.     5.2.1 Roche (CH)
  81.       5.2.1.1 Financial Overview
  82.       5.2.1.2 Products Offered
  83.       5.2.1.3 Key Developments
  84.       5.2.1.4 SWOT Analysis
  85.       5.2.1.5 Key Strategies
  86.     5.2.2 Thermo Fisher Scientific (US)
  87.       5.2.2.1 Financial Overview
  88.       5.2.2.2 Products Offered
  89.       5.2.2.3 Key Developments
  90.       5.2.2.4 SWOT Analysis
  91.       5.2.2.5 Key Strategies
  92.     5.2.3 Illumina (US)
  93.       5.2.3.1 Financial Overview
  94.       5.2.3.2 Products Offered
  95.       5.2.3.3 Key Developments
  96.       5.2.3.4 SWOT Analysis
  97.       5.2.3.5 Key Strategies
  98.     5.2.4 Novartis (CH)
  99.       5.2.4.1 Financial Overview
  100.       5.2.4.2 Products Offered
  101.       5.2.4.3 Key Developments
  102.       5.2.4.4 SWOT Analysis
  103.       5.2.4.5 Key Strategies
  104.     5.2.5 GSK (GB)
  105.       5.2.5.1 Financial Overview
  106.       5.2.5.2 Products Offered
  107.       5.2.5.3 Key Developments
  108.       5.2.5.4 SWOT Analysis
  109.       5.2.5.5 Key Strategies
  110.     5.2.6 Bristol-Myers Squibb (US)
  111.       5.2.6.1 Financial Overview
  112.       5.2.6.2 Products Offered
  113.       5.2.6.3 Key Developments
  114.       5.2.6.4 SWOT Analysis
  115.       5.2.6.5 Key Strategies
  116.     5.2.7 Pfizer (US)
  117.       5.2.7.1 Financial Overview
  118.       5.2.7.2 Products Offered
  119.       5.2.7.3 Key Developments
  120.       5.2.7.4 SWOT Analysis
  121.       5.2.7.5 Key Strategies
  122.     5.2.8 Merck KGaA (DE)
  123.       5.2.8.1 Financial Overview
  124.       5.2.8.2 Products Offered
  125.       5.2.8.3 Key Developments
  126.       5.2.8.4 SWOT Analysis
  127.       5.2.8.5 Key Strategies
  128.     5.2.9 Amgen (US)
  129.       5.2.9.1 Financial Overview
  130.       5.2.9.2 Products Offered
  131.       5.2.9.3 Key Developments
  132.       5.2.9.4 SWOT Analysis
  133.       5.2.9.5 Key Strategies
  134.   5.3 Appendix
  135.     5.3.1 References
  136.     5.3.2 Related Reports
  137. 6 LIST OF FIGURES
  138.   6.1 MARKET SYNOPSIS
  139.   6.2 INDIA MARKET ANALYSIS BY PRODUCT
  140.   6.3 INDIA MARKET ANALYSIS BY APPLICATION
  141.   6.4 INDIA MARKET ANALYSIS BY END-USER
  142.   6.5 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS
  143.   6.6 RESEARCH PROCESS OF MRFR
  144.   6.7 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS
  145.   6.8 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
  146.   6.9 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
  147.   6.10 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS
  148.   6.11 SECURITY, ACCESS CONTROL AND ROBOTICS, BY PRODUCT, 2024 (% SHARE)
  149.   6.12 SECURITY, ACCESS CONTROL AND ROBOTICS, BY PRODUCT, 2024 TO 2035 (USD Billion)
  150.   6.13 SECURITY, ACCESS CONTROL AND ROBOTICS, BY APPLICATION, 2024 (% SHARE)
  151.   6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY APPLICATION, 2024 TO 2035 (USD Billion)
  152.   6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END-USER, 2024 (% SHARE)
  153.   6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END-USER, 2024 TO 2035 (USD Billion)
  154.   6.17 BENCHMARKING OF MAJOR COMPETITORS
  155. 7 LIST OF TABLES
  156.   7.1 LIST OF ASSUMPTIONS
  157.     7.1.1
  158.   7.2 India MARKET SIZE ESTIMATES; FORECAST
  159.     7.2.1 BY PRODUCT, 2025-2035 (USD Billion)
  160.     7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  161.     7.2.3 BY END-USER, 2025-2035 (USD Billion)
  162.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  163.     7.3.1
  164.   7.4 ACQUISITION/PARTNERSHIP
  165.     7.4.1

India Security, Access Control and Robotics Market Segmentation

Security, Access Control and Robotics By Product (USD Billion, 2025-2035)

  • Personalized Medicine Diagnostics
  • Personalized Medicine Therapeutics
  • Personalized Medical Care
  • Personalized Nutrition and Wellness

Security, Access Control and Robotics By Application (USD Billion, 2025-2035)

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Others

Security, Access Control and Robotics By End-User (USD Billion, 2025-2035)

  • Hospitals
  • Diagnostic Centers
  • Research & Academic Institutes
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓